Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: A prospective study

International Journal of Urology

Volumn 17, Issue 8, 2010, Pages 715-719

  Shoji, Sunao ^a   Nakano, Mayura ^a   Nagata, Yoshihiro ^a   Usui, Yukio ^b   Terachi, Toshiro ^b   Uchida, Toyoaki ^a  

^a TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

high intensity focused ultrasound; prostate cancer; quality of life

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER THERAPY; CONTROLLED STUDY; DATA BASE; FLOW RATE; FUNCTIONAL ASSESSMENT; HIGH INTENSITY FOCUSED ULTRASOUND; HORMONAL THERAPY; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; JAPANESE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RESIDUAL URINE; SEXUAL HEALTH; URINARY EXCRETION; ADVERSE EFFECTS; CLINICAL TRIAL; DISEASE FREE SURVIVAL; ERECTILE DYSFUNCTION; MIDDLE AGED; PROSTATIC NEOPLASMS; URINATION DISORDERS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL; URINATION DISORDERS;

EID: 77954915664     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02568.x     Document Type: Article

References (19)

1. Madersbacher S, Pedevilla M, Vingers L, Susani M, Marberger M. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res. 1995 55 : 3346 3351.
2. Uchida T, Shoji S, Nakano M et al. Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience. Int. J. Urol. 2009 16 : 881 886.
3. Roach M, Hanks G, Thames H et al. Defining biochemical failure following radiotherapy with or without hormone therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int. J. Radiat. Oncol. Biol. Phys. 2006 65 : 965 997.
4. Cella DF, Tulsky DS, Gray G et al. The functional assessment of cancer therapy scale: Development and validation of the general measure. J. Clin. Oncol. 1993 11 : 570 579.
5. Fumimoto H, Kobayashi K, Chang CH et al. Cross-cultural validation of an international questionnaire, the General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese. Qual. Life Res. 2001 10 : 701 709.
6. Esper P, Mo F, Chodak G et al. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 1997 50 : 920 928.
7. Rosen RC, Riley A, Wagner G et al. The international index of erectile function(IIEF): a multidimensional scale for assessment of erectile dysfunction. Urlogy. 1997 49 : 822 830.
8. Rhoden E, Teloken C, Sogari R, Souto C. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int. J. Impot. Res. 2002 14 : 245 250.
9. Blana A, Hierl J, Rogenhofer S et al. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer. Urology 2008 71 : 863 867.
10. Chaussy C, Thüroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr. Urol. Rep. 2003 4 : 248 252.
11. Hamada Y, Kitani K, Kawano T et al. Assessment of Quality of life in men treated for localized prostate cancer: before and after radical prostatectomy. Nishinihon J. Urol. 2004 66 : 241 248.
12. Clark JA, Inui TS, Silliman RA et al. Patients' perceptions of quality of life after treatment for early prostatic cancer. J. Clin. Oncol. 2003 21 : 3777 3784.
13. Litwin MS, Lubeck DP, Spitalny GM, Henning JM, Carroll PR. Mental health in men treated for early stage prostate carcinoma: A posttreatment, longitudinal quality of life analysis from the cancer of the prostate strategic urologic research endeavor. Cancer 2002 95 : 54 60.
14. Clark JA, Bokhour BG, Inui TS, Silliman RA, Talcott JA. Measuring patients' perceptions of the outcomes of treatment for early prostate cancer. Med. Care 2003 41 : 923 936.
15. Bradley E, Bissonette E, Theodorescu D. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer. BJU Int. 2004 94 : 1003 1009.
16. Hanlon L, Watkins D, Peter R, Hanks E. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 2001 51 : 614 623.
17. Sanda MG, Dunn RL, Michalski J et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl. J. Med. 2008 358 : 1250 1261.
18. Merrick GS, Butler WM, Galbreath RW et al. Erectile function after permanent prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 2002 52 : 893 902.
19. Poel HG, Blok W. Role of extent of fascia preservation and erectile function after robot-assisted laparoscopic prostatectomy. Urology 2009 73 : 816 821.